Found: 31
Select item for more details and to access through your institution.
Administration of ferric derisomaltose for iron deficiency and heart failure during hospital admission or at the clinic – insights from the IRONMAN trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 10, p. 2293, doi. 10.1002/ejhf.3394
- By:
- Publication type:
- Article
A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 7, p. 1666, doi. 10.1093/ndt/gfac305
- By:
- Publication type:
- Article
The 'other' big complication: how chronic kidney disease impacts on cancer risks and outcomes.
- Published in:
- Nephrology Dialysis Transplantation, 2023, v. 38, n. 5, p. 1071, doi. 10.1093/ndt/gfac011
- By:
- Publication type:
- Article
Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics.
- Published in:
- European Heart Journal, 2023, v. 44, n. 31, p. 2966, doi. 10.1093/eurheartj/ehad341
- By:
- Publication type:
- Article
Temporal trends in the incidence of malignancy in heart failure: a nationwide Danish study.
- Published in:
- European Heart Journal, 2023, v. 44, n. 13, p. 1124, doi. 10.1093/eurheartj/ehac797
- By:
- Publication type:
- Article
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.
- Published in:
- European Heart Journal, 2022, v. 43, n. 4, p. 280, doi. 10.1093/eurheartj/ehab674
- By:
- Publication type:
- Article
EMPEROR-REDUCED reigns while EMPERIAL whimpers.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Cardiovascular effects of urocortin 2 and urocortin 3 in patients with chronic heart failure.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 82, n. 4, p. 974, doi. 10.1111/bcp.13033
- By:
- Publication type:
- Article
Rotigaptide protects the myocardium and arterial vasculature from ischaemia reperfusion injury.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 81, n. 6, p. 1037, doi. 10.1111/bcp.12882
- By:
- Publication type:
- Article
Effect of hypoglycaemia on measures of myocardial blood flow and myocardial injury in adults with and without type 1 diabetes: A prospective, randomised, open‐label, blinded endpoint, cross‐over study.
- Published in:
- Endocrinology, Diabetes & Metabolism, 2021, v. 4, n. 3, p. 1, doi. 10.1002/edm2.258
- By:
- Publication type:
- Article
Mechanisms shared between cancer, heart failure, and targeted anti-cancer therapies.
- Published in:
- Cardiovascular Research, 2022, v. 118, n. 18, p. 3451, doi. 10.1093/cvr/cvac132
- By:
- Publication type:
- Article
The Chief Scientist Office Cardiovascular and Pulmonary Imaging in SARS Coronavirus disease-19 (CISCO-19) study.
- Published in:
- Cardiovascular Research, 2020, v. 116, n. 14, p. 2185, doi. 10.1093/cvr/cvaa209
- By:
- Publication type:
- Article
Vericiguat in worsening heart failure: agonising over, or celebrating, agonism in the VICTORIA trial.
- Published in:
- Cardiovascular Research, 2020, v. 116, n. 12, p. e152, doi. 10.1093/cvr/cvaa247
- By:
- Publication type:
- Article
Measuring congestion with a non‐invasive monitoring device in heart failure and haemodialysis: CONGEST‐HF.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 6, p. 1383, doi. 10.1002/ejhf.3290
- By:
- Publication type:
- Article
Characteristics and outcomes of patients with a history of cancer recruited to heart failure trials.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 488, doi. 10.1002/ejhf.2818
- By:
- Publication type:
- Article
Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cardiotoxicity and myocardial hypoperfusion associated with anti-vascular endothelial growth factor therapies: prospective cardiac magnetic resonance imaging in patients with cancer.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Personalized medicine and hospitalization for heart failure: if we understand it, we may be successful in treating it.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: associations with mortality in a haemodialysis cohort.
- Published in:
- Clinical Kidney Journal, 2023, v. 16, n. 3, p. 512, doi. 10.1093/ckj/sfac248
- By:
- Publication type:
- Article
Left ventricular dysfunction with preserved ejection fraction: the most common left ventricular disorder in chronic kidney disease patients.
- Published in:
- Clinical Kidney Journal, 2022, v. 15, n. 12, p. 2186, doi. 10.1093/ckj/sfac146
- By:
- Publication type:
- Article
UVA Irradiation of Human Skin Vasodilates Arterial Vasculature and Lowers Blood Pressure Independently of Nitric Oxide Synthase.
- Published in:
- Journal of Investigative Dermatology, 2014, v. 134, n. 7, p. 1839, doi. 10.1038/jid.2014.27
- By:
- Publication type:
- Article
Cisplatin related cardiotoxicity – acute and chronic cardiovascular morbidity in a testicular cancer survivor.
- Published in:
- Scottish Medical Journal, 2020, v. 65, n. 1, p. 24, doi. 10.1177/0036933019897347
- By:
- Publication type:
- Article
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS‐MI): rationale and design.
- Published in:
- ESC Heart Failure, 2024, v. 11, n. 4, p. 2001, doi. 10.1002/ehf2.14830
- By:
- Publication type:
- Article
Intravenous iron and SGLT2 inhibitors in iron‐deficient patients with heart failure and reduced ejection fraction.
- Published in:
- ESC Heart Failure, 2024, v. 11, n. 4, p. 1875, doi. 10.1002/ehf2.14742
- By:
- Publication type:
- Article
Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Mechanistic science in cardiovascular-oncology: the way forward to maximise anti-cancer drug effects and minimise cardiovascular toxicity.
- Published in:
- Clinical Science, 2021, v. 135, n. 23, p. 2661, doi. 10.1042/CS20210986
- By:
- Publication type:
- Article
Clonal haematopoiesis of indeterminate potential: intersections between inflammation, vascular disease and heart failure.
- Published in:
- Clinical Science, 2021, v. 135, n. 7, p. 991, doi. 10.1042/CS20200306
- By:
- Publication type:
- Article
Cardiotoxic effects of angiogenesis inhibitors.
- Published in:
- Clinical Science, 2021, v. 135, n. 1, p. 71, doi. 10.1042/CS20200305
- By:
- Publication type:
- Article
Vascular toxicity associated with anti-angiogenic drugs.
- Published in:
- Clinical Science, 2020, v. 134, n. 18, p. 2503, doi. 10.1042/CS20200308
- By:
- Publication type:
- Article
Role of asymmetric methylarginine and connexin 43 in the regulation of pulmonary endothelial function.
- Published in:
- Pulmonary Circulation, 2013, v. 3, n. 3, p. 675, doi. 10.1086/674440
- By:
- Publication type:
- Article
Vascular PAR-1: Activity and Antagonism.
- Published in:
- Cardiovascular Therapeutics, 2011, v. 29, n. 6, p. 349, doi. 10.1111/j.1755-5922.2010.00140.x
- By:
- Publication type:
- Article